Pharmabiz
 

Allocation for Central sector schemes and projects under DoHFW may decline 25% in Budget 2023-24

Gireesh Babu, New DelhiFriday, February 3, 2023, 08:00 Hrs  [IST]

The budget allocation for the Central sector schemes and projects under the Department of Health and Family Welfare (DoHFW), which include the National Pharmacovigilance Programme and the Pradhan Mantri Swasthya Suraksha Yojana, is expected to see a decline of over 25 per cent in the fiscal year 2023-24 compared to the revised estimates for the previous financial year.

The central sector schemes and projects under the Department of Health Research (DHR) are also estimated to see a seven per cent decline in budget allocation for the year 2023-24 compared to the revised estimates for the fiscal year 2022-23, according to the Demands for Grants projected in the Union Budget, 2023-24.

The total budget estimate for the Central Sector Schemes and Projects under the DoHFW for the year 2023-24 is Rs. 8,820.27 crore, as compared to Rs. 11,868.63 crore as per the Revised Estimate (RE) for the year 2022-23. It may be noted that the Revised Estimates have seen a decline compared to the Budget Estimate (BE) of Rs. 15,163.22 crore during the year 2022-23.

Under the schemes, the Pradhan Mantri Swasthya Suraksha Yojana will have an allocation of Rs. 3,365 crore for 2023-24, as compared to the Rs. 8,269.56 crore under the revised estimates for the previous year. It may be noted that BE for the year 2022-23 for the Yojana was Rs. 10,000 crore.

The budget allocation for National AIDS and STD Control Programme will see an increase to Rs. 3,079.97 crore during 2023-24, as compared to the RE of Rs. 2,182.01 crore for the year 2022-23. Similarly, the fresh addition of Rs. 495 crore under the Global Fund Grant under Covid-19 Response Mechanism 2021, will also add to the total budget allocation for the upcoming financial year.

According to the data, the National Pharmacovigilance Programme, which received a budget allocation of Rs. 10 crore in the previous fiscal year, will have an allocation of Rs. 8.53 crore in the next fiscal year.

Allocation for Health Sector Disaster Preparedness and Response and Human Resources Development for Emergency Medical Services is expected to see an increase to Rs. 128.14 crore as compared to the allocation of Rs. 75 crore in the RE for 2022-23.

National Digital Health Mission, which focuses on digital health initiatives in the country, will have an allocation of Rs. 341.02 crore as compared to Rs. 140 crore allocated as per the RE 2022-23.

The other Central sector expenditure, for the regulatory and statutory bodies is also expected to see a marginal uptake to Rs. 639.10 crore as compared to Rs. 635 crore under the RE 2022-23. The Budget allocation for this, as per the BE 2022-23 was Rs. 335.14 crore. The regulatory and statutory bodies include the Indian Pharmacopoeia Commission, National Medical Commission, Pharmacy Council of India, among others.

The All India Institute of Medical Sciences (AIIMS), New Delhi will get an allocation of Rs. 4,134.67 crore under Budget 2023-24, as against Rs. 4,400.24 crore under the RE 2022-23. The total allocation to autonomous bodies including AIIMS, New Delhi, Post Graduate Institute of Medical Education and Research, Chandigarh, and Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, is expected to go 67 per cent up to Rs. 17,322.55 crore as compared to the Rs. 10,348.17 crore under the RE 2022-23.

The total budget allocation for the DoHFW for the year 2023-24 is Rs. 86,175 crore, as compared to Rs. 76,370.40 crore under the RE for the fiscal year 2022-23, with an increase of around 13 per cent.

The establishment expenditure of the centre, which includes the salaries for various government offices under the Department, is expected to go up to Rs. 7,697.64 crore as compared to Rs. 6,912.66 crore as per the RE for 2022-23. The other hospitals and institutions expenditure, which include the establishment expenditure for subordinate offices such as the Central Drugs Standard Control Organisation and institutions of medical education, will have an allocation of Rs. 1,067.59 crore, as compared to Rs. 953.90 crore in the RE of 2022-23.

For the Central sector schemes and projects under the Department of Health Research, which include setting up of nationwide network of laboratories for managing epidemics and national calamities, development of infrastructure for promotion of health research and Prime Minister's Ayushman Bharat Health Infrastructure Mission (PM-ABHIM)-Bio Security Preparedness and strengthening Pandemic Research and Multi Sector and National Institutions and Platform for One Health, will have 7.8 per cent decline in budget allocation at Rs. 566.42 crore for the BE 2023-24, as compared to RE of Rs. 614.92 crore for the year 2022-23.

The Indian Council of Medical Research (ICMR), New Delhi, the apex body in the country to promote, co-ordinate and formulate biomedical and health research, will have an allocation of Rs. 2,359.58 crore, with more than 11 per cent increase compared to Rs. 2,116.73 crore under the RE for 2022-23. Central
government gives grants to the Council for research in health, nutrition, non-communicable diseases and basic research. The Council is also engaged in research on tribal health, traditional medicine and publication and dissemination of information.

The Central Sector Schemes, along with the allocation for ICMR, has reported a growth to Rs. 2,980 crore compared to Rs. 2,775 crore. The Budget allocation for the schemes and ICMR was Rs. 3,200.65 crore as per the BE for 2022-23, which has seen a decline in the revised estimates.

 
[Close]